36 related articles for article (PubMed ID: 27044904)
1. Docking-Based 3D-QSAR Studies for 1,3,4-oxadiazol-2-one Derivatives as FAAH Inhibitors.
Zięba A; Laitinen T; Patel JZ; Poso A; Kaczor AA
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34204026
[TBL] [Abstract][Full Text] [Related]
2. New molecular insights into the tyrosyl-tRNA synthase inhibitors: CoMFA, CoMSIA analyses and molecular docking studies.
Li S; Fan J; Peng C; Chang Y; Guo L; Hou J; Huang M; Wu B; Zheng J; Lin L; Xiao G; Chen W; Liao G; Guo J; Sun P
Sci Rep; 2017 Sep; 7(1):11525. PubMed ID: 28912450
[TBL] [Abstract][Full Text] [Related]
3. 3D-QSAR-based design, synthesis and biological evaluation of 2,4-disubstituted quinoline derivatives as antimalarial agents.
Vyas VK; Bhati S; Sharma M; Gehlot P; Patel N; Dalai S
SAR QSAR Environ Res; 2023; 34(8):639-659. PubMed ID: 37651746
[TBL] [Abstract][Full Text] [Related]
4. Refinement and 3D-QSAR Studies of Inhibitors of Cyclophilin A Containing Amide Linker.
Fan F; Zhu J; Ni S; Cheng J; Tang Y; Kang C; Li J; Jiang H
QSAR Comb Sci; 2009 Feb; 28(2):183-193. PubMed ID: 32327951
[TBL] [Abstract][Full Text] [Related]
5. 3D-QSAR Modeling on 2-Pyrimidine Carbohydrazides as Utrophin Modulators for the Treatment of Duchenne Muscular Dystrophy by Combining CoMFA, CoMSIA, and Molecular Docking Studies.
Mahmoudzadeh Laki R; Pourbasheer E
ACS Omega; 2024 Jun; 9(23):24707-24720. PubMed ID: 38882130
[TBL] [Abstract][Full Text] [Related]
6. 3D-QSAR AND CONTOUR MAP ANALYSIS OF TARIQUIDAR ANALOGUES AS MULTIDRUG RESISTANCE PROTEIN-1 (MRP1) INHIBITORS.
Kakarla P; Inupakutika M; Devireddy AR; Gunda SK; Willmon TM; Ranjana KC; Shrestha U; Ranaweera I; Hernandez AJ; Barr S; Varela MF
Int J Pharm Sci Res; 2016 Feb; 7(2):554-572. PubMed ID: 26913287
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, lipoxygenase inhibition activity and molecular docking of oxamide derivative.
Fazal-Ur-Rehman S; Wasim AA; Iqbal S; Khan MA; Lateef M; Iqbal L
Pak J Pharm Sci; 2019 May; 32(3 (Supplementary)):1253-1259. PubMed ID: 31303598
[TBL] [Abstract][Full Text] [Related]
8. CoMFA/CoMSIA/HQSAR and Docking Study of the Binding Mode of Selective Cyclooxygenase (COX-2) Inhibitors.
Chen H; Li Q; Yao X; Fan B; Yuan S; Panaye A; Doucet JP
QSAR Comb Sci; 2004 Feb; 23(1):36-55. PubMed ID: 32327948
[TBL] [Abstract][Full Text] [Related]
9. Activity-Based Probes for 15-Lipoxygenase-1.
Eleftheriadis N; Thee SA; Zwinderman MR; Leus NG; Dekker FJ
Angew Chem Int Ed Engl; 2016 Sep; 55(40):12300-5. PubMed ID: 27612308
[TBL] [Abstract][Full Text] [Related]
10. Exploring details about structure requirements based on antioxidant tripeptide derived from β-Lactoglobulin by in silico approaches.
Wang F; Wen M; Zhou B
Amino Acids; 2023 Dec; 55(12):1909-1922. PubMed ID: 37917178
[TBL] [Abstract][Full Text] [Related]
11. Qualitative and Quantitative analysis of 3D predicted arachidonate 15-lipoxygenase-B (15-LOX-2) from Homo sapiens.
Arora N; Singh VK; Shah K; Pandey-Rai S
Bioinformation; 2012; 8(12):555-61. PubMed ID: 22829730
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the inhibitory activity of ferrocenyl Schiff bases derivatives on 5-lipoxygenase: Computational and biological studies.
Navarrete E; Morales P; Muñoz-Osses M; Vásquez-Martínez Y; Godoy F; Maldonado T; Martí AA; Flores E; Mascayano C
J Inorg Biochem; 2023 Aug; 245():112233. PubMed ID: 37141763
[TBL] [Abstract][Full Text] [Related]
13. Quantum mechanics and 3D-QSAR studies on thienopyridine analogues: inhibitors of IKKβ.
Ul-Haq Z; Khan A; Ashraf S; Morales-Bayuelo A
Heliyon; 2020 Jun; 6(6):e04125. PubMed ID: 32566780
[TBL] [Abstract][Full Text] [Related]
14. Molecular modelling studies of quinazolinone derivatives as MMP-13 inhibitors by QSAR, molecular docking and molecular dynamics simulations techniques.
Huang S; Feng K; Ren Y
Medchemcomm; 2019 Jan; 10(1):101-115. PubMed ID: 30774858
[TBL] [Abstract][Full Text] [Related]
15. Active site characterization and structure based 3D-QSAR studies on non-redox type 5-lipoxygenase inhibitors.
Ul-Haq Z; Khan N; Zafar SK; Moin ST
Eur J Pharm Sci; 2016 Jun; 88():26-36. PubMed ID: 27044904
[TBL] [Abstract][Full Text] [Related]
16. CoMFA and CoMSIA studies on 5-hydroxyindole-3-carboxylate derivatives as 5-lipoxygenase inhibitors: generation of homology model and docking studies.
Aparoy P; Suresh GK; Kumar Reddy K; Reddanna P
Bioorg Med Chem Lett; 2011 Jan; 21(1):456-62. PubMed ID: 21084193
[TBL] [Abstract][Full Text] [Related]
17. A ligand-based comparative molecular field analysis (CoMFA) and homology model based molecular docking studies on 3', 4'-dihydroxyflavones as rat 5-lipoxygenase inhibitors: Design of new inhibitors.
Ahamed TKS; Muraleedharan K
Comput Biol Chem; 2017 Dec; 71():188-200. PubMed ID: 29112937
[TBL] [Abstract][Full Text] [Related]
18. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models.
Bhongade BA; Gadad AK
J Med Chem; 2006 Jan; 49(2):475-89. PubMed ID: 16420035
[TBL] [Abstract][Full Text] [Related]
19. Review in quantitative structure activity relationships on lipoxygenase inhibitors.
Eleni P; Dimitra HL
Mini Rev Med Chem; 2003 Aug; 3(5):487-99. PubMed ID: 12769699
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
